Evaxion
Phase 2AI-Immunology™ allows for ground-breaking development of novel personalized and precision vaccines for cancer and infectious diseases. The platform consists of a collection of unique in-house developed AI building blocks that can be intelligently combined to generate tailored AI prediction models addressing complex immune-related healthcare issues.
About
AI-Immunology™ allows for ground-breaking development of novel personalized and precision vaccines for cancer and infectious diseases. The platform consists of a collection of unique in-house developed AI building blocks that can be intelligently combined to generate tailored AI prediction models addressing complex immune-related healthcare issues.
Funding History
4Total raised: $45M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile